Why Did Geode Capital Increase Holdings in Ligand Pharmaceuticals?

2 min read | December 24, 2024 03:41 AM PST | By Team Kalkine Media

Highlights

  • Geode Capital increases its stake in Ligand Pharmaceuticals.
  • Ligand Pharmaceuticals operates in the biotechnology sector.
  • SEC filing reveals Geode Capital's updated holdings.

Ligand Pharmaceuticals (NASDAQ:LGND), a biotechnology company, focuses on developing innovative technology platforms for pharmaceutical research. According to recent filings with the Securities and Exchange Commission (SEC), Geode Capital Management LLC has expanded its position in the company. Biotechnology remains a critical area for pharmaceutical advancements, and Ligand Pharmaceuticals holds a significant presence within this sector.

Details of Geode Capital's Holdings

Geode Capital increased its stake in Ligand Pharmaceuticals by acquiring additional shares during the third quarter. The fund now owns over four hundred thousand shares, which represents a substantial portion of its investments in the biotechnology field. As of the filing, this stake accounts for a significant value based on Ligand Pharmaceuticals' current market positioning.

Industry Impact

The biotechnology sector continues to drive research innovation, with companies like Ligand Pharmaceuticals playing a pivotal role in developing cutting-edge solutions. Updates on institutional investments, such as those made by Geode Capital, underscore the significance of advancements within the pharmaceutical industry. Regulatory filings provide valuable insights into the operations and strategic movements in the sector, offering a clear view of institutional participation.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next